Entropy measures quantify global splicing disorders in cancer

PLoS Computational Biology

Volumn 4, Issue 3, 2008, Pages

  Ritchie, William ^a   Granjeaud, Samuel ^a   Puthier, Denis ^a   Gautheret, Daniel ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DISEASES; HISTOLOGY; MAMMALS; TISSUE; TRANSCRIPTION; UNCERTAINTY ANALYSIS;

ALTERNATIVE SPLICING; CANCER TISSUES; ENTROPY GAIN; ENTROPY MEASURE; ISOFORMS; MAMMALIAN GENES; NORMAL TISSUE; POLYADENYLATION; SPLICE VARIANTS; THERAPEUTIC TARGETS;

ENTROPY;

RNA; TUMOR MARKER; TUMOR PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER TISSUE; CELL DISRUPTION; CELL PROLIFERATION; ENTROPY; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC VARIABILITY; NEOPLASM; POLYADENYLATION; PROTEIN VARIANT; RNA SPLICING; TRANSCRIPTION INITIATION; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MUTATION; PROTEIN PROCESSING; STATISTICAL MODEL;

MAMMALIA;

ALTERNATIVE SPLICING; COMPUTER SIMULATION; ENTROPY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN SPLICING; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS);

EID: 41849110528     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000011     Document Type: Article

References (38)

1. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, et al. (2005) The Transcriptional Landscape of the Mammalian Genome. Science 309: 1559-1563.
2. Tress ML, Martelli PL, Frankish A, Reeves GA, Wesselink JJ, et al. (2007) The implications of alternative splicing in the ENCODE protein complement. Proc Natl Acad Sci U S A 104: 5495-5500.
3. Zavolan M, Kondo S, Schonbach C, Adachi J, Hume DA, et al. (2003) Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome. Genome Res 13: 1290-1300.
4. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. (2003) Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays. Science 302: 2141-2144.
5. Pan Q, Shai O, Misquitta C, Zhang W, Saltzman AL, et al. (2004) Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol Cell 16: 929-941.
6. Xu Q, Modrek B, Lee C (2002) Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucl Acids Res 30: 3754-3766.
7. Zhang H, Lee J, Tian B (2005) Biased alternative polyadenylation in human tissues. Genome Biology 6: R100.
8. Woolard J, Wang W-Y, Bevan HS, Qiu Y, Morbidelli L, et al. (2004) VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant: Mechanism of Action, In vivo Effect On Angiogenesis and Endogenous Protein Expression. Cancer Res 64: 7822-7835.
9. Sturla LM, Merrick AE, Burchill SA (2003) FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. Br J Cancer 89: 1276-1284.
10. Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J, et al. (2004) Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23: 9369-9380.
11. Srebrow A, Kornblihtt AR (2006) The connection between splicing and cancer. J Cell Sci 119: 2635-2641.
12. Venables JP (2004) Aberrant and alternative splicing in cancer. Cancer Res 64: 7647-7654.
13. Mazoyer S, Puget N, Perrin-Vidoz L, Lynch HT, Serova-Sinilnikova OM, et al. (1998) A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet 62: 713-715.
14. Cheng C, Sharp PA (2006) Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol 26: 362-370.
15. Stoilov P, Daoud R, Nayler O, Stamm S (2004) Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum Mol Genet 13: 509-524.
16. Watermann DO, Tang Y, Zur Hausen A, Jager M, Stamm S, et al. (2006) Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res 66: 4774-4780.
17. Ghigna C, Giordano S, Shen H, Benvenuto F, Castiglioni F, et al. (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20: 881-890.
18. Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, et al. (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14: 185-193.
19. Maeda T, Hiranuma H, Jikko A (1999) Differential expression of the splicing regulatory factor genes during two-step chemical transformation in a BALB/3T3-derived cell line, MT-5. Carcinogenesis 20: 2341-2344.
20. Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, et al. (2004) Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing. Mol Carcinog 41: 187-196.
21. Roy M, Xu Q, Lee C (2005) Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res 33: 5026-5033.
22. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
23. Kelso J, Visagie J, Theiler G, Christoffels A, Bardien S, et al. (2003) eVOC: a controlled vocabulary for unifying gene expression data. Genome Res 13: 1222-1230.
24. Sorek R, Shamir R, Ast G (2004) How prevalent is functional alternative splicing in the human genome? Trends Genet 20: 68-71.
25. Le Texier V, Riethoven JJ, Kumanduri V, Gopalakrishnan C, Lopez F, et al. (2006) AltTrans: transcript pattern variants annotated for both alternative splicing and alternative polyadenylation. BMC Bioinformatics 7: 169.
26. Stuart JM, Segal E, Koller D, Kim SK (2003) A gene-coexpression network for global discovery of conserved genetic modules. Science 302: 249-255.
27. Puthier D, Joly F, Irla M, Saade M, Victorero G, et al. (2004) A general survey of thymocyte differentiation by transcriptional analysis of knockout mouse models. J Immunol 173: 6109-6118.
28. Jumaa H, Nielsen PJ (1997) The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. Embo J 16: 5077-5085.
29. Xu Q, Lee C (2003) Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 31: 5635-5643.
30. Fischer DC, Noack K, Runnebaum IB, Watermann DO, Kieback DG, et al. (2004) Expression of splicing factors in human ovarian cancer. Oncol Rep 11: 1085-1090.
31. Stickeler E, Kittrell F, Medina D, Berget SM (1999) Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582.
32. Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE (2007) Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446: 926-929.
33. Ni JZ, Grate L, Donohue JP, Preston C, Nobida N, et al. (2007) Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev 21: 708-718.
34. Garcia-Blanco MA, Baraniak AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22: 535-546.
35. Hayes GM, Carrigan PE, Beck AM, Miller LJ (2006) Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Res 66: 3819-3827.
36. Pilch B, Allemand E, Facompre M, Bailly C, Riou JF, et al. (2001) Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res 61: 6876-6884.
37. Tian B, Pan Z, Lee JY (2007) Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res 17: 156-165.
38. Martin D, Brun C, Remy E, Mouren P, Thieffry D, et al. (2004) GOToolBox: functional analysis of gene datasets based on Gene Ontology. Genome Biol 5: R101.